How is the 180 Life Sciences Corp today?

The 180 Life Sciences Corp today is trading in the down by -1.90% at 1.03.

What is 180 Life Sciences Corp Annual Net Profit?

180 Life Sciences Corp Annual Net Profit rose 69.06% in the last year to $6.17 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is 180 Life Sciences Corp Price to Earning Ratio?

180 Life Sciences Corp Price to Earning Ratio is -0.79, which is negative.

What is 180 Life Sciences Corp Stock Price?

180 Life Sciences Corp Stock Price fell 48.24% and underperformed its sector by 59.79% in the past year.

What is 180 Life Sciences Corp Quarterly Net profit?

180 Life Sciences Corp Quarterly Net profit fell 121.48% YoY to $2.37 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is 180 Life Sciences Corp Debt to Equity Ratio?

180 Life Sciences Corp Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is 180 Life Sciences Corp Return on Equity(ROE)?

180 Life Sciences Corp Return on Equity(ROE) for the last financial year was -310.82%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is 180 Life Sciences Corp Mutual Fund Holding?

180 Life Sciences Corp Mutual Fund Holding increased by 0.07% in the last quarter to 1.14.

What is 180 Life Sciences Corp Interest Coverage Ratio?

180 Life Sciences Corp Interest Coverage Ratio is -126.65, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is 180 Life Sciences Corp Institutional Holding?

180 Life Sciences Corp Institutional Holding decreased by 4.84% in the last quarter to 4.48.

180 Life Sciences Corp XNAS: ATNF

180 Life Sciences Corp Live Share Price Today, Share Analysis and Chart

Name: 180 Life Sciences Corp: Is Infosys Ltd. worth buying?
Item: 180 Life Sciences Corp
Rating: 1.10458325
Author: Trendlyne DVM scores

about

180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination the...

1.03 -0.02 (-1.90%)

94.20% Fall from 52W High

42,120 XNAS Volume

XNAS 22 May, 2025 4:00 PM (EDT)

Not Eligible

-

Expensive Valuation

12.8 / 100

Technically Bearish

31.4 / 100

No estimates available

180 Life Sciences Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

180 Life Sciences Corp FAQ

How is 180 Life Sciences Corp today?

180 Life Sciences Corp today is trading in the red, and is down by -1.90% at 1.03.

How has 180 Life Sciences Corp performed historically?

180 Life Sciences Corp is currently trading down -1.90% on an intraday basis. In the past week the stock fell -7.21%. stock has been down -17.60% in the past quarter and fell -48.24% in the past year. You can view this in the overview section.